
0.5178 Delayed Data As of Dec 06 | ![]() Today’s Change | 0.41 Today|||52-Week Range 3.19 | -77.09% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $98.2M |
Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco California 94158 |
Howard W. Robin | President, Chief Executive Officer & Director |
Sandra A. Gardiner | Chief Financial & Accounting Officer |
Mary Tagliaferri | Chief Medical Officer |
Jonathan Zalevsky | Chief Research & Development Officer |
Mark A. Wilson | Secretary, Chief Legal Officer & Senior VP |